Category Archives: Z Medical centers

Google wants your medical records

Posted on March 24, 2019 by admin

December 19, 2013- Interviewed by Steven E. Greer, MD In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University,

Posted in - Biotech, - Policy, Columbia, FDA, Genetics | Leave a comment

Apple, Google, and Amazon need to make their own hospitals

Posted on March 24, 2019 by admin

Update February 27, 2018- Well, they used my idea from two-years ago. Amazon, Warren Buffet,

Posted in - Medical Devices, - Opinion, CMS, Congress, Z Medical centers | Leave a comment

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

Posted on March 20, 2019 by admin

 April 21, 2015- By Steven E. Greer, MD Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals,

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

Don Berwick, MD: State health insurance exchanges

Posted on February 11, 2019 by admin

April 4, 2012

Posted in CMS, Congress, Harvard | Leave a comment

Don Berwick, MD: Changing from fee-for-service to bundled payments in Medicare and Medicaid

Posted on February 11, 2019 by admin

April 4, 2012

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: National Coverage Decisions

Posted on February 11, 2019 by admin

December 1, 2013- National Coverage Decisions (NCDs) are used by CMS to set guidelines as to

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: The Institute for Healthcare Improvement

Posted on February 11, 2019 by admin
Posted in CMS, Harvard | Leave a comment

Industry conflicts arise at PCORI threatening any real comparative effectiveness research

Posted on February 10, 2019 by admin

February 7, 2014- By Steven E. Greer, MD The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010.

Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale | Leave a comment

Review of immunotherapy and targeted therapy

Posted on January 5, 2019 by admin

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

Insurance companies are not paying for Repatha and Praluent

Posted on December 15, 2018 by admin

Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

Posted on December 1, 2018 by admin

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | Leave a comment

Book Review: Fat Chance by Robert H. Lustig, MD

Posted on October 25, 2018 by admin

February 9, 2013- by Steven E. Greer, MD How did our ancient ancestors evolve from being pure meat eating carnivore hunters into grain fed

Posted in - Reviews, books, devices, Bariatric surgery, FDA, Gastroenterology and liver, Internal Medicine, Pediatrics, Primary care medicine, UC San Francisco | Leave a comment

Does President Trump have “heart disease” based on his Coronary Calcium Score?

Posted on October 7, 2018 by admin

January 20, 2018- by Steven E. Greer, MD President Trump made news this week by having his doctor, Admiral Ronny Jackson, MD, answer

Posted in - NEJM, - Opinion, - Policy, Cardiac surgery, Cardiology, CDC, Emory, Internal Medicine, Neurosurgery, NIH | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

Posted on September 1, 2018 by admin

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

Posted on September 1, 2018 by admin

March 19, 2013- Interviewed by Steven E. Greer, MD The upcoming ASCO meeting will be dominated by numerous presentations relating to new

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Gluten Crazies are out of control and affecting menus in restaurants

Posted on March 2, 2018 by admin

April 26, 2015- By Steven E. Greer, MD I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”.

Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics | Leave a comment

Bending the cost curve of cancer care

Posted on February 26, 2018 by admin

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

Posted on February 24, 2018 by admin

September 12, 2016- by Steven E. Greer, MD Once again, the Hillary Clinton campaign is on defense after another health scare from their

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

Posted on February 23, 2018 by admin

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Hormone replacement therapy is safe and effective after all

Posted on January 31, 2018 by admin

November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment